143 related articles for article (PubMed ID: 36513192)
21. Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy.
Zhao J; Dean DC; Hornicek FJ; Yu X; Duan Z
Cancer Lett; 2020 Apr; 474():158-167. PubMed ID: 31987920
[TBL] [Abstract][Full Text] [Related]
22. Role of miRNA-542-5p in the tumorigenesis of osteosarcoma.
Zhu T; Fan D; Ye K; Liu B; Cui Z; Liu Z; Tian Y
FEBS Open Bio; 2020 Apr; 10(4):627-636. PubMed ID: 32105410
[TBL] [Abstract][Full Text] [Related]
23. Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma.
Tavanti E; Sero V; Vella S; Fanelli M; Michelacci F; Landuzzi L; Magagnoli G; Versteeg R; Picci P; Hattinger CM; Serra M
Br J Cancer; 2013 Nov; 109(10):2607-18. PubMed ID: 24129234
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
Zhu KP; Zhang CL; Shen GQ; Zhu ZS
Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
[TBL] [Abstract][Full Text] [Related]
25. New molecular insights into osteosarcoma targeted therapy.
Yang J; Zhang W
Curr Opin Oncol; 2013 Jul; 25(4):398-406. PubMed ID: 23666471
[TBL] [Abstract][Full Text] [Related]
26. Innovative target mining stratagems to navigate drug repurposing endeavours.
Saravanan KS; Satish KS; Saraswathy GR; Kuri U; Vastrad SJ; Giri R; Dsouza PL; Kumar AP; Nair G
Prog Mol Biol Transl Sci; 2024; 205():303-355. PubMed ID: 38789185
[TBL] [Abstract][Full Text] [Related]
27. High Expression of N-Acetylgalactosaminyl-transferase 1 (GALNT1) Associated with Invasion, Metastasis, and Proliferation in Osteosarcoma.
Zhang L; Lv B; Shi X; Gao G
Med Sci Monit; 2020 Dec; 26():e927837. PubMed ID: 33284788
[TBL] [Abstract][Full Text] [Related]
28. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
Islam T; Rahman MR; Aydin B; Beklen H; Arga KY; Shahjaman M
Eur J Pharmacol; 2020 Nov; 887():173594. PubMed ID: 32971089
[TBL] [Abstract][Full Text] [Related]
29. Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma.
Reddy GB; Kerr DL; Spasojevic I; Tovmasyan A; Hsu DS; Brigman BE; Somarelli JA; Needham D; Eward WC
Mol Cancer Ther; 2020 Jul; 19(7):1448-1461. PubMed ID: 32371588
[TBL] [Abstract][Full Text] [Related]
30. Predicting novel genes and pathways associated with osteosarcoma by using bioinformatics analysis.
Dong B; Wang G; Yao J; Yuan P; Kang W; Zhi L; He X
Gene; 2017 Sep; 628():32-37. PubMed ID: 28687333
[TBL] [Abstract][Full Text] [Related]
31. Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples.
Ho XD; Phung P; Q Le V; H Nguyen V; Reimann E; Prans E; Kõks G; Maasalu K; Le NT; H Trinh L; G Nguyen H; Märtson A; Kõks S
Exp Biol Med (Maywood); 2017 Dec; 242(18):1802-1811. PubMed ID: 29050494
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel miRNA-target gene regulatory network in osteosarcoma by integrating transcriptome analysis.
He C; Gao H; Fan X; Wang M; Liu W; Huang W; Yang Y
Int J Clin Exp Pathol; 2015; 8(7):8348-57. PubMed ID: 26339404
[TBL] [Abstract][Full Text] [Related]
33. Comparative oncology approach to drug repurposing in osteosarcoma.
Parrales A; McDonald P; Ottomeyer M; Roy A; Shoenen FJ; Broward M; Bruns T; Thamm DH; Weir SJ; Neville KA; Iwakuma T; Fulbright JM
PLoS One; 2018; 13(3):e0194224. PubMed ID: 29579058
[TBL] [Abstract][Full Text] [Related]
34. CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma.
Gerardo-Ramírez M; Keggenhoff FL; Giam V; Becker D; Groth M; Hartmann N; Straub BK; Morrison H; Galle PR; Marquardt JU; Herrlich P; Hartmann M
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955749
[TBL] [Abstract][Full Text] [Related]
35. Integrative analyses of key genes and regulatory elements in fluoride-affected osteosarcoma.
Li M; Jin X; Guo F; Wu G; Wu L; Deng S
J Cell Biochem; 2019 Sep; 120(9):15397-15409. PubMed ID: 31037778
[TBL] [Abstract][Full Text] [Related]
36. Multiscale topology in interactomic network: from transcriptome to antiaddiction drug repurposing.
Du H; Wei GW; Hou T
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38499497
[TBL] [Abstract][Full Text] [Related]
37. An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.
Hill KE; Kelly AD; Kuijjer ML; Barry W; Rattani A; Garbutt CC; Kissick H; Janeway K; Perez-Atayde A; Goldsmith J; Gebhardt MC; Arredouani MS; Cote G; Hornicek F; Choy E; Duan Z; Quackenbush J; Haibe-Kains B; Spentzos D
J Hematol Oncol; 2017 May; 10(1):107. PubMed ID: 28506242
[TBL] [Abstract][Full Text] [Related]
38. Identification of differentially expressed genes in the development of osteosarcoma using RNA-seq.
Yang Y; Zhang Y; Qu X; Xia J; Li D; Li X; Wang Y; He Z; Li S; Zhou Y; Xie L; Yang Z
Oncotarget; 2016 Dec; 7(52):87194-87205. PubMed ID: 27888627
[TBL] [Abstract][Full Text] [Related]
39. Combined analysis of DNA methylation and gene expression profiles of osteosarcoma identified several prognosis signatures.
Tian W; Li Y; Zhang J; Li J; Gao J
Gene; 2018 Apr; 650():7-14. PubMed ID: 29407229
[TBL] [Abstract][Full Text] [Related]
40. Key genes with prognostic values in suppression of osteosarcoma metastasis using comprehensive analysis.
Li M; Jin X; Li H; Wu G; Wang S; Yang C; Deng S
BMC Cancer; 2020 Jan; 20(1):65. PubMed ID: 31992246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
